Penumbra Inc

PEN: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
&lfLOCK|@bLOCK|>tsXC!

Penumbra Earnings: Solid Quarterly Results as Firm Awaits Closure of Boston Acquisition

Penumbra reported third-quarter results that featured double-digit revenue growth across both segments, with thrombectomy up 18% and embolization and access up 11% year over year. Neurovascular sales were up 19% off a small base.

Sponsor Center